Evidence map›Paper›PMID 31824157›Full record

ArticleInternational journal of nanomedicine2019

Preparation and Characterization of Fe

Xinyu Dai, Jingqing Yao, Yuejiao Zhong, Yuntao Li, Qianling Lu, Yan Zhang, Xue Tian, Zhirui Guo, Tingting Bai

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Rapid Detection Method for PathogenicInternational journal of nanomedicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xinyu DaiDepartment of Neurology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Jingqing YaoDepartment of Neurology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Yuejiao ZhongDepartment of Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Yuntao LiDepartment of General Practice, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Qianling LuDepartment of Neurology, Third Affiliated Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Yan ZhangDepartment of Neurology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Xue TianDepartment of Neurology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Zhirui GuoDepartment of Geratology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Tingting BaiDepartment of Geratology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, People's Republic of China.
Second Affiliated Hospital of Nanjing Medical University · CNNanjing Medical University · CNNanjing Traditional Chinese Medicine Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary central nervous system lymphomas (PCNSL) are extranodal malignant non-Hodgkin lymphomas (NHL) that arise exclusively in central nervous system (CNS). Diffuse large B-cell lymphoma (DLBCL) is the most common histological subtype. PURPOSE: To evaluate whether nano drug-loading system-mediated magnetic-targeted thermochemotherapy could produce a better therapeutic effect than single chemotherapy while reducing the use of chemotherapeutic drugs.

methodsSix groups (control, Fe

resultsIn vitro, compared with chemotherapy alone, apoptosis rate of Fe

conclusionThese results demonstrated in vivo and in vitro that the combined thermochemotherapy of Fe

Indexed as

Hyperthermia, Induced3T3 CellsAnimalsApoptosisCell Line, TumorCentral Nervous System NeoplasmsDisease Models, AnimalDrug Delivery SystemsDrug LiberationFemaleFerric CompoundsHumansLymphomaMagnetite NanoparticlesMaleMethotrexateFerric Compoundsferric oxideMagnetite NanoparticlesMethotrexateFe3O4@MTX magnetic nanoparticleshyperthermiaMNPsOCI-LY18 cellsPCNSLprimary central nervous lymphoma

Identifiers

PMID31824157
PMCPMC6901047
OpenAlexW2993245088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.